IRT vs. RTSM: What's The Difference? What Sponsors Need To Know When Choosing Clinical Trial Technology

By Heather Nonnemacher, Director of Services Solutions

The debate between IRT (Interactive Response Technology) and RTSM (Randomization and Trial Supply Management) often boils down to a choice between historical legacy and functional precision. While IRT originated in the era of voice-response systems, RTSM centers on the system’s modern purpose: protecting study blind integrity and orchestrating complex drug logistics.

For clinical supply managers and study leads, navigating these "regional terminology traps" is less about settling on a label and more about ensuring the underlying architecture can handle the rigors of modern trials. Shifting focus toward supply intelligence allows teams to prioritize performance over semantics. That includes the ability to automate resupply, minimize waste, and maintain real-time visibility from depot to site. By understanding how these terms evolved, sponsors and CROs can better evaluate technology based on its ability to integrate seamlessly with EDC/eCOA platforms and adapt to mid-study changes, ultimately ensuring that patient safety and scientific validity remain the top priorities.